The Substance Use Disorder Workforce in Rural Communities: Challenges and Opportunities

Current Status
Not Enrolled
Price
Free
Get Started

Course Description

The Greater Southern California Node (GSCN) of the National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN), in partnership with the Pacific Southwest Addiction Technology Transfer Center (PSATTC), presents a 4-part training series addressing the implementation and sustainability of medications for opioid use disorders (MOUD) in rural settings. The series is hosted by Larissa Mooney, M.D., who is a Professor of Clinical Psychiatry and the Director of the Addiction Psychiatry Division in the Department of Psychiatry and Biomedical Sciences at UCLA. She is also a Principal Investigator for the GSCN of the NIDA CTN.

This on-demand course is the fourth session in a 4-part series that addresses the strengths and challenges to providing MOUD in rural communities. When a clinic has committed to providing MOUD to treat patients with opioid use disorder (OUD), it is critical to prepare administrative and clinical staff, and ensure the clinical workforce is trained and confident in their ability to use medications for opioid use disorders (MOUD). This session discussed strategies and tools for ensuring clinic readiness and best practices for offering MOUD. Speakers discussed ways to identify and engage site champions and other providers as they integrate MOUD into clinic workflows. Presenters also discussed a systems approach to preparing clinical staff and community partners for using medication, including how to identify specialty care if needed for rural patients with OUD.

Please note, individuals can earn free CMEs and CEs for their attendance and sessions do not build on one another; individuals are free to select which topics are most relevant to them.

Launch Date: May 5, 2023

At the conclusion of the on-demand course, participants will be able to:

  1. Recognize two (2) workforce challenges in providing MOUD care in rural settings.
  2. Explain two (2) workforce roles on MOUD treatment teams and discuss the critical role of Champions.
  3. Review two (2) possible workflows, and explain the training and certifications required for specific team members to implement MOUD.

Instructions for Continuing Education Credits

How to receive a CE/CME certificate:

For Continuing Medical Education (CME) for physicians, physician assistants, nurses, and nurse practitioners only, you will receive a link to complete the course evaluation for CME after watching the video for this course, and you will receive your CE certificate via email within six to eight weeks.

If you have any UCLA ISAP CME-related questions, please contact Gloria Miele at gmiele@mednet.ucla.edu.

CME Statements:

Please view the linked CME Learner Handout for more information about how to obtain CME credit.

The training course meets the qualifications for the provision of one (1) continuing medical education credit/contact hour (CME/CEH).

UCLA Integrated Substance Abuse Programs (ISAP) is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

UCLA Integrated Substance Abuse Programs (ISAP) designates this learning course for a maximum of one (1) AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 CreditsTM (rn.ca.gov). Nurses will receive a Certificate of Participation following this activity that may be used for license renewal.

Continuing medical education will be awarded within 6-8 weeks following completion of the training.

Continuing Education: 

The on-demand course meets the qualifications for the provision of one (1) continuing education credit/contact hour (CE/CEH). UCLA Integrated Substance Abuse Programs (ISAP) is approved by the American Psychological Association to sponsor continuing education for psychologists. UCLA ISAP maintains responsibility for this program and its content.

UCLA ISAP is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for LMFTs, LCSWs, LPCCs, and/or LEPs (Provider #64812). UCLA ISAP maintains responsibility for this program/course and its content. Course meets the qualifications for one hour of continuing education credit for LMFTs, LCSWs, LPCCs, and LEPs as required by the California Board of Behavioral Sciences. UCLA ISAP is also an approved provider of continuing education for RADTs I/II, CADCs-CASs, CADCs I/II, CADCs-CSs, and LAADCs (CCAPP, #2N-21-339-1225), CATCs (ACCBC/ CAADE, #CP40 872 C 0825), and CAODCs (CADTP, #151).

CE credit will be awarded at the conclusion of the training. Upon completing the final module, you must pass the final test with a minimum of 80% correct. Once you pass the final test, it will display a link to complete a course evaluation and submit the required information for your CE certificate. Upon completing this required course evaluation, you will receive your CE certificate via email within six to eight weeks.

If you have any CE-related questions, please contact Darren Manley at dmanley@mednet.ucla.edu.

Estimated time to complete the course:

This course should take approximately one (1) hour to complete.

Cost:

Free

Disclosure statements:

Allison Ober, MSW, PhD, Senior Health Policy and Behavioral Science Researcher – RAND Corporation

Kathy Pinnell, RN-MSN, Nurse, Mount Carmel Hospital

Grace-Katie Bell, MSN, RN-BC, CARN, PHN, MAT/SUD consultant – Center for Care Innovation

Moderated by Thomas E. Freese, PhD, Co-Director, UCLA Integrated Substance Abuse Programs

None of the presenters, planners, or others in control of content for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Presenters:

Allison Ober, MSW, PhD, Senior Health Policy and Behavioral Science Researcher – RAND Corporation

Kathy Pinnell, RN-MSN, Nurse, Mount Carmel Hospital

Grace-Katie Bell, MSN, RN-BC, CARN, PHN, MAT/SUD consultant – Center for Care Innovation

Moderated by Thomas E. Freese, PhD, Co-Director, UCLA Integrated Substance Abuse Programs

Recommended Audience:

This online course is recommended for primary clinicians and community health providers who are involved in providing multidisciplinary care to persons with opioid, stimulant, and other substance use disorders, including, but not limited to:

  • Physicians
  • Physician Assistants
  • Nurse Practitioners
  • Registered Nurses and LVNs
  • Psychologists
  • Marriage and Family Therapists
  • Social Workers
  • Alcohol and Other Drug and Mental Health Counselors
  • Case Managers
  • Medical Assistants

Instructions for Requesting Accommodations for Disability:

If you need a disability-related reasonable accommodation/alternative format for this event, please contact Darren Manley at dmanley@mednet.ucla.edu.

Instructions for Filing a Grievance Concerning UCLA ISAP’s Continuing Education Program:

Please contact Dr. Thomas E. Freese, CE Program Administrator, in writing: (UCLA ISAP, 10911 Weyburn Ave, Suite 200, Los Angeles, CA 90024) or by phone (310-267-5397). Alternately, you may contact Dr. Gloria Miele or Dr. James Peck, ISAP-affiliated doctoral-level psychologists responsible for program planning for the ISAP CE Program. Drs. Miele and Peck can be reached in writing at: 10911 Weyburn Ave, Suite 200, Los Angeles, CA 90024 or by phone at: 310-267-5888 (Miele) or 310-267-5346 (Peck).

Please click on the lesson below to start the course.